Archives
FDA Approves Johnson & Johnson's Olysio for Hepatitis C Virus Infection Treatment
The U.S. Food and Drug Administration has approved Johnson & Johnson's 'Olysio' for treating hepatitis C virus infection, the agency announced Friday.
Latest Research Articles
Stem Cells from the Umbilical Cord Used to Grow Artificial Skin
Fear of Offending Others May Prompt Unhealthy Food Choices Around the Holidays
Gamma-ray Burst Brightest Ever Detected [VIDEO]
Environmental Group Criticizes India and Saudi Arabia for Role at UN Climate Talks
Moose-eating Shark Beached in Canada, Saved by Locals
New Details of Glacier Melt Could Mean Better Sea Level Rise Forecasts
Excessive TV for Preschoolers can Stall Cognitive Development
Siats meekerorum: New Carnivorous Dinosaur Species Kept T. Rex in Check
NASA's LADEE Spacecraft Enters Unique Lunar Orbit
Satellite Trio to Study the Earth's Magnetic Field in Unprecedented Detail
Galaxy Trio Discovered Caught Merging Near 'Cosmic Dawn'
Bigger Dishware May Cause Children to Overeat [VIDEO]
MOST POPULAR
-
Mount Rainier's Volcanic Activity Closely Watched by Scientists
-
Earth's Magnetic North Pole Shifts Toward Russia, Scientists Update Its Location
-
How Earthquakes 'Ignite': Hidden Mechanism Discovered in New Study
-
Chinese Astronauts Create Oxygen and Rocket Fuel Using Artificial Photosynthesis in Space
-
Contagious Urination Confirmed in Chimpanzees for the First Time, Surprising Researchers
